Clinical Trials Directory

Trials / Conditions / T Lymphoblastic Leukemia/Lymphoma

T Lymphoblastic Leukemia/Lymphoma

11 registered clinical trials studyying T Lymphoblastic Leukemia/Lymphoma — 5 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingPhase II Trial of S101 Autologous Anti-CD7 CAR-T Cells in Patients With R/R T-LBL/ALL.
NCT07244380
Hebei Senlang Biotechnology Inc., Ltd.Phase 2
RecruitingSupCD7 CART for Relapsed or Refractory CD7 Positive Hematologic Malignancies
NCT07153068
Institute of Hematology & Blood Diseases Hospital, ChinaPhase 1 / Phase 2
RecruitinguCD7 CART for Relapsed or Refractory CD7 Positive Hematologic Malignancies
NCT07109518
Institute of Hematology & Blood Diseases Hospital, ChinaPhase 1
RecruitingVenetoclax and Decitabine in R/R T-ALL
NCT06712121
Seoul National University HospitalPhase 2
CompletedLow-dose Chidamide Maintenance Therapy After Allo-HSCT for T-cell Acute Lymphoblastic Leukemia or T-cell Lymph
NCT05991973
Zhejiang UniversityPhase 2
RecruitingCD7 CAR-T Cells in T-cell Lymphoma/Leukemia
NCT05620680
Shenzhen University General HospitalN/A
CompletedAnti-CD7 CAR-T Cell Therapy for Relapse and Refractory CD7 Positive T Cell Malignancies
NCT05290155
Shanghai General Hospital, Shanghai Jiao Tong University School of MedicinePhase 1
UnknownHumanized CD7 CAR T-cell Therapy for r/r CD7+ Acute Leukemia
NCT04762485
The First Affiliated Hospital of Soochow UniversityPhase 1 / Phase 2
UnknownCD7-CART in the Treatment of r / r CD7 Positive Hemolymph System Malignancies on Increasing Dose and Open Labe
NCT04480788
PersonGen BioTherapeutics (Suzhou) Co., Ltd.Phase 1
CompletedRomidepsin Maintenance After Allogeneic Stem Cell Transplantation
NCT02512497
Ohio State University Comprehensive Cancer CenterPhase 1
CompletedSalvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin Lymphoma
NCT02652715
Mayo ClinicN/A